Clinical Trials for Arvinas

Explore 10 clinical trials worldwide

Showing 1-10 of 10 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: Arvinas

Clinical Trials (10)

NCT07023731
A Study to Evaluate ARV-806 in Adults With Advanced Cancer That Has the KRAS G12D Mutation
PHASE1/PHASE2Recruiting
159 participants
Started: May 29, 2025 · Completed: Apr 2, 2029
2 conditions1 sponsor4 locations
NCT06393738
A Study of ARV-393 in Relapsed/Refractory Non-Hodgkin Lymphoma.
PHASE1Recruiting
112 participants
Started: Sep 5, 2024 · Completed: Dec 31, 2025
2 conditions1 sponsor17 locations
NCT06206837
A Study to Learn About Vepdegestrant When Given With PF-07220060 to People With Advanced or Metastatic Breast Cancer.
PHASE1/PHASE2Active, not recruiting
71 participants
Started: Feb 19, 2024 · Completed: Mar 6, 2026
1 condition2 sponsors54 locations
NCT06125522
TACTIVE-U: A Study to Learn About the Study Medicine (Vepdegestrant) When Given With Other Medicines in People With Advanced or Metastatic Breast Cancer. (Sub-Study C)
PHASE1/PHASE2Active, not recruiting
11 participants
Started: Jan 10, 2024 · Completed: Nov 4, 2025
1 condition3 sponsors21 locations
NCT05909397
A Study of Vepdegestrant (ARV-471, PF-07850327) Plus Palbociclib Versus Letrozole Plus Palbociclib in Participants With Estrogen Receptor Positive, Human Epidermal Growth Factor Negative Advanced Breast Cancer
PHASE3Active, not recruiting
59 participants
Started: Aug 9, 2023 · Completed: Dec 30, 2026
1 condition2 sponsors28 locations
NCT05654623
A Study to Learn About a New Medicine Called Vepdegestrant (ARV-471, PF-07850327) in People Who Have Advanced Metastatic Breast Cancer
PHASE3Active, not recruiting
624 participants
Started: Mar 3, 2023 · Completed: May 15, 2028
1 condition2 sponsors312 locations
NCT05573555
TACTIVE-U: A Study to Learn About the Study Medicine (Vepdegestrant) When Given With Other Medicines in People With Advanced or Metastatic Breast Cancer (Sub-Study B)
PHASE1/PHASE2Active, not recruiting
20 participants
Started: Mar 1, 2023 · Completed: Dec 30, 2026
1 condition2 sponsors29 locations
NCT05548127
TACTIVE-U: A Study to Learn About the Study Medicine (Vepdegestrant) When Given With Other Medicines in People With Advanced or Metastatic Breast Cancer (Sub-Study A)
PHASE1/PHASE2Active, not recruiting
37 participants
Started: Feb 23, 2023 · Completed: Mar 1, 2026
1 condition2 sponsors36 locations
NCT05463952
A Study to Learn About the Vepdegestrant (ARV-471, PF-07850327) in People With ER+/HER2- Locally Advanced or Metastatic Breast Cancer (BC)
PHASE1Active, not recruiting
6 participants
Started: Aug 16, 2022 · Completed: Mar 31, 2025
1 condition2 sponsors3 locations
NCT04072952
A Phase 1/2 Trial of ARV-471 Alone and in Combination With Palbociclib (IBRANCE®) in Patients With ER+/HER2- Locally Advanced or Metastatic Breast Cancer
PHASE1/PHASE2Active, not recruiting
217 participants
Started: Aug 5, 2019 · Completed: Nov 30, 2025
1 condition2 sponsors16 locations